Chinese english Germany Japanese Korea

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI)

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI) Struktur
244206-51-7
CAS-Nr.
244206-51-7
Englisch Name:
19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI)
Synonyma:
Ulipristal Impurity 29;19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI)
CBNumber:
CB412694437
Summenformel:
C30H41NO6
Molgewicht:
511.66
MOL-Datei:
244206-51-7.mol
Request For Quotation

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI) Eigenschaften

Siedepunkt:
699.9±55.0 °C(Predicted)
Dichte
1.32±0.1 g/cm3(Predicted)
pka
14.69±0.70(Predicted)

Sicherheit

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 7934 55
guoyungurui 18162595016
 3287908757@qq.com China 10012 58
  • 19-Norpregn-9-ene-3,20-dione, 11-(4-aminophenyl)-5,17-dihydroxy-, cyclic bis(1,2-ethanediyl acetal), (5α,11β)- (9CI)
  • Ulipristal Impurity 29
  • 244206-51-7
Copyright 2019 © ChemicalBook. All rights reserved